08:25:58 EDT Sun 08 Sep 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:HSCS - HEART TEST LABORATORIES IN - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
HSCS - Q0.52.90·3.370.12.94-0.1201-3.913.9381253.22  3.235  2.9485.18  3.030116:00:01Jul 2915 min RT 2¢

Recent Trades - Last 10 of 125
Time ETExPriceChangeVolume
16:00:01Q3.01-0.219
16:00:01Q3.01-0.2110
15:59:51Q2.93-0.2957
15:59:51Q2.93-0.2938
15:51:02Q3.0299-0.12011,700
15:51:02Q3.0299-0.1201300
15:46:22Q2.94-0.288
15:45:07Q2.97-0.251
15:44:39Q2.95-0.2712
15:44:09Q2.99-0.239

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-07-29 16:05U:HSCSNews ReleaseHeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results
2024-07-26 09:00U:HSCSNews ReleaseInnovation Value Institute Analysis Demonstrates HeartSciences' MyoVista(TM) wavECG(TM) Potential to Improve Cardiovascular Pathway Efficiency
2024-07-25 08:30U:HSCSNews ReleaseHeartSciences Selected to Demonstrate MyoVista(TM) wavECG(TM) at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare
2024-07-11 09:00U:HSCSNews ReleaseHeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction
2024-06-04 16:15U:HSCSNews ReleaseHeartSciences Regains Compliance with Nasdaq Listing Requirements
2024-05-20 09:00U:HSCSNews ReleaseHeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio
2024-04-24 09:00U:HSCSNews ReleaseHeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
2024-04-02 16:15U:HSCSNews ReleaseHeartSciences to Present at the LD Micro Invitational XIV Conference
2024-03-26 09:00U:HSCSNews ReleaseHeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista(TM) Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
2024-03-14 16:15U:HSCSNews ReleaseHeartSciences Reports Third Quarter Fiscal 2024 Financial Results
2024-03-12 09:00U:HSCSNews ReleaseHeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista(TM) Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes
2024-03-06 09:00U:HSCSNews ReleaseHeartSciences Announces Canada Patent Grant Covering MyoVista(TM) Wavelet Technology
2024-02-26 09:00U:HSCSNews ReleaseHeartSciences Adds Key Advisor to its Scientific Advisory Board
2024-02-12 09:00U:HSCSNews ReleaseHeartSciences Expands its Scientific Advisory Board
2024-02-01 09:00U:HSCSNews ReleaseHeartSciences Appoints New Scientific Advisory Board Member
2024-01-18 08:00U:HSCSNews ReleaseHeartSciences Announces Results and Adjournment of Annual Shareholder Meeting
2024-01-03 16:15U:HSCSNews ReleaseHeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting
2023-12-14 16:15U:HSCSNews ReleaseHeartSciences Reports Second Quarter Fiscal 2024 Financial Results
2023-12-05 08:00U:HSCSNews ReleaseHeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway
2023-11-20 08:00U:HSCSNews ReleaseHeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms